Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Cash from Operations (2020 - 2026)

SkinHealth Systems has reported Cash from Operations over the past 6 years, most recently at 15196000.0 for Q4 2025.

  • Quarterly Cash from Operations fell 7.75% to 15196000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 37485000.0 through Dec 2025, up 132.34% year-over-year, with the annual reading at 37485000.0 for FY2025, 132.34% up from the prior year.
  • Cash from Operations was 15196000.0 for Q4 2025 at SkinHealth Systems, up from 9647000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 21966000.0 in Q2 2023 and troughed at 38471000.0 in Q1 2022.
  • The 5-year median for Cash from Operations is 2128500.0 (2021), against an average of 2979600.0.
  • Year-over-year, Cash from Operations skyrocketed 55285.19% in 2021 and then tumbled 10637.25% in 2022.
  • A 5-year view of Cash from Operations shows it stood at 3279000.0 in 2021, then plummeted by 264.47% to 5393000.0 in 2022, then grew by 4.13% to 5170000.0 in 2023, then soared by 418.61% to 16472000.0 in 2024, then decreased by 7.75% to 15196000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Cash from Operations are 15196000.0 (Q4 2025), 9647000.0 (Q3 2025), and 9646000.0 (Q2 2025).